Research Paper Volume 14, Issue 23 pp 9617—9631
A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
Figure 4. Development of a prognostic nomogram. (A) Pathological N, the pathological T, and the newly-established signature were selected as effective indicators. (B) A nomogram was constructed. (C) The ROC curve demonstrated an elevated forecasting performance, and five-year AUC value was 0.708 (D) Calibration curve revealed that the calculated probability line was highly compatible with observed probability line.